US Gov't Wins Appeal Over COVID-19 Vaccine Patent
The U.S. government has won a second shot at patenting a technique to make coronavirus spike proteins for use in vaccines, as a European appellate panel found that an amended version...To view the full article, register now.
Already a subscriber? Click here to view full article